2. Koparde AA, Doijad RC, Magdum CS, Koparde AA, Doijad RC, Magdum CS. Natural products in drug discovery. In Pharmacogn-Med Plants. IntechOpen, 2019.
3. Akram M, Tahir IM, Shah SMA. Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review.
Phytother Res 2018;32:811-22.DOI:
10.1002/ptr.6024. PMID:
29356205.
4. Allam SF, Soudy BA, Hassan AS, Ramadan MM, Baker DA. How do mentha plants induce resistance against Tetranychus urticae (Acari: Tetranychidae) in organic farming? J Plant Prot Res 2018;58:265-75.
5. Koul B, Taak P, Kumar A, Khatri T, Sanyal I. The
Artemisia genus: A review on traditional uses, phytochemical constituents, pharmacological properties and germplasm Conservation.
J Glycomics Lipidomics 2018;07:1000142.DOI:
10.4172/2153-0637.1000142.
7. Orosco FL. Current progress in diagnostics, therapeutics, and vaccines for African swine fever virus.
Vet Integr Sci 2023;21:751-81.DOI:
10.12982/VIS.2023.054.
8. Khan FA, Khan NM, Ahmad S Nasruddin, Aziz R, Ullah I, et al. Phytochemical profiling, antioxidant, antimicrobial and cholinesterase inhibitory effects of essential oils isolated from the leaves of
Artemisia scoparia and
Artemisia absinthium.
Pharmaceuticals 2022;15:1221.DOI:
10.3390/ph15101221. PMID:
36297333. PMCID:
PMC9607455.
10. Taleghani A, Emami SA, Tayarani-Najaran Z.
Artemisia: A promising plant for the treatment of cancer.
Bioorg Med Chem 2020;28:115180.DOI:
10.1016/j.bmc.2019.115180. PMID:
31784199.
11. Talman AM, Clain J, Duval R, Ménard R, Ariey F. artemisinin bioactivity and resistance in malaria parasites.
Trends Parasitol 2019;35:953-63.DOI:
10.1016/j.pt.2019.09.005. PMID:
31699532.
13. Guibourt NJBG. Historia natural de las drogas simples o... Imp. de D.Manuel A.Gil;1852.
14. Al-Sanafi AE. The pharmacological importance of Artemsia campestris-A review. Asian J Pharm Res 2015;5:88-92.
15. Apaza Ticona L, Bermejo P, Guerra JA, Abad MJ, Beltrán M, Martín Lázaro R, et al. Ethanolic extract of
Artemisia campestris subsp. glutinosa (Besser) Batt. inhibits HIV-1 replication in vitro through the activity of terpenes and flavonoids on viral entry and NF-κB pathway.
J Ethnopharmacol 2020;263:113163.DOI:
10.1016/j.jep.2020.113163. PMID:
32758575. PMCID:
PMC7397943.
16. Breverton T, Culpeper N. breverton's complete herbal: A book of remarkable plants and their uses. London: Quercus;2011.
17. Palmer G. Shuswap indian ethnobotany. Syesis 1975;8:29-81.
18. Kadi I, Ouinten M, Gourine N, Yousfi M. Synergistic antinociceptive activity of combined aqueous extracts of
Artemisia campestris and
Artemisia herba-alba in several acute pain models.
Nat Prod Res 2019;33:875-8.DOI:
10.1080/14786419.2017.1410802. PMID:
29210306.
19. Ghlissi Z, Sayari N, Kallel R, Bougatef A, Sahnoun Z. Antioxidant, antibacterial, anti-inflammatory and wound healing effects of
Artemisia campestris aqueous extract in rat.
Biomed Pharmacother 2016;84:115-22.DOI:
10.1016/j.biopha.2016.09.018. PMID:
27643553.
20. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China.
JAMA Intern Med 2020;180:934-43.DOI:
10.1001/jamainternmed.2020.0994. PMID:
32167524. PMCID:
PMC7070509.
22. Rolta R, Salaria D, Sharma P Sharma B, Kumar V, Rathi B, et al. Phytocompounds of
Rheum emodi, Thymus serpyllum, and
Artemisia annua inhibit spike protein of SARS-CoV-2 binding to ACE2 receptor: In silico approach.
Curr Pharmacol Rep 2021;7:135-49.DOI:
10.1007/s40495-021-00259-4. PMID:
34306988. PMCID:
PMC8279807.
23. Cao R, Hu H, Li Y, Wang X, Xu M, Liu J, et al. Anti-SARS-CoV-2 potential of artemisinins
in vitro.
ACS Infect Dis 2020;6:2524-31.DOI:
10.1021/acsinfecdis.0c00522. PMID:
32786284.
24. Nair MS, Huang Y, Fidock DA, Polyak SJ, Wagoner J, Towler MJ, et al.
Artemisia annua L. extracts inhibit the
in vitro replication of SARS-CoV-2 and two of its variants. 2021:274:114016.DOI:
10.1016/j.jep.2021.114016. PMID:
33716085. PMCID:
PMC7952131.
25. Gendrot M, Duflot I, Boxberger M, Delandre O, Jardot P, Le Bideau M, et al. Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate.
Int J Infect Dis 2020;99:437-40.DOI:
10.1016/j.ijid.2020.08.032. PMID:
32805422. PMCID:
PMC7426697.
26. Li G, Yuan M, Li H, Deng C, Wang Q, Tang Y, et al. Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial.
Int J Antimicrob Agents 2021;57:106216.DOI:
10.1016/j.ijantimicag.2020.106216. PMID:
33152450. PMCID:
PMC7605811.
27. Evans RM, Lippman SM. Shining light on the COVID-19 pandemic: A vitamin D receptor checkpoint in defense of unregulated wound healing.
Cell Metab 2020;32:704-9.DOI:
10.1016/j.cmet.2020.09.007. PMID:
32941797. PMCID:
PMC7486067.
28. Orosco FL. Immune evasion mechanisms of porcine epidemic diarrhea virus: A comprehensive review. Vet Integr Sci 2024;22:171-92.
29. Cao Y, Feng YH, Gao LW, Li XY, Jin QX, Wang YY, et al. Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo.
Int Immunopharmacol 2019;70:110-6.DOI:
10.1016/j.intimp.2019.01.041. PMID:
30798159.
30. Trieu V, Saund S, Rahate PV, Barge VB, Nalk S, Windlass H, et al. Targeting TGF-β pathway with COVID-19 drug candidate ARTIVeda/PulmoHeal accelerates recovery from mild-moderate COVID-19.
Clin Invest 2021;11:10-8.DOI:
10.1101/2021.01.24.21250418.
31. Richard M, van den Brand JMA, Bestebroer TM, Lexmond P, de Meulder D, Fouchier RAM, et al. Influenza A viruses are transmitted via the air from the nasal respiratory epithelium of ferrets.
Nat Commun 2020;11:766.DOI:
10.1038/s41467-020-14626-0. PMCID:
PMC7005743.
32. Mahedi MRA, Rawat A, Rabbi F, Babu KS, Tasayco ES, Areche F, et al. Understanding the global transmission and demographic distribution of Nipah virus (NiV).
Res J Pharm Technol 2023;16:3588-94.DOI:
10.52711/0974-360X.2023.00592.
33. Motlhatlego KE, Mehrbod P, Fotouhi F, Abdalla MA, Eloff JN, McGaw LJ. Anti-influenza A virus activity of two Newtonia species and the isolated compound myricetin-3-o-rhamnoside.
BMC Complement Med Ther 2021;21:92.DOI:
10.1186/s12906-021-03250-0. PMID:
33726731. PMCID:
PMC7961164.
34. Hegazy A, Mostafa I, Elshaier YAMM, Mahmoud SH, Abo Shama NM, Shehata M, et al. robust antiviral activity of santonica flower extract (
Artemisia cina) against avian and human influenza A viruses:
In vitro and chemoinformatic studies.
ACS Omega 2022;7:41212-23.DOI:
10.1021/acsomega.2c04867. PMID:
36406485. PMCID:
PMC9670689.
35. Ponticelli M, Bellone ML, Parisi V, Iannuzzi A, Braca A, de Tommasi N, et al. Specialized metabolites from plants as a source of new multi-target antiviral drugs: a systematic review.
Phytochem Rev 2023;22:615-93.DOI:
10.1007/s11101-023-09855-2. PMID:
37359711. PMCID:
PMC10008214.
36. Nigam M, Atanassova M, Mishra AP, Pezzant R, Devkota HP, Plygun S, et al. Bioactive compounds and health benefits of
Artemisia species.
Nat Prod Commun 2019;14:1934578X19850354.DOI:
10.1177/1934578X19850354.
37. Yong J, Aisa HA. chemical modification of rupestonic acid and preliminarily
in vitro antiviral activity against influenza A3 and B viruses.
Bull Korean Chem Soc 2011;32:1293-7.DOI:
10.5012/bkcs.2011.32.4.1293.
38. Ou L, Qin K, Yang ZX, Bie MJ. The effects and mechanisms of dihydroartemisinin on influenza A Virus H1N1 induces TNF-α and IL-6 expression in bronchial epithelial cells. Sichuan Da Xue Xue Bao Yi Xue Ban 2020;51:171-7.
39. Lubbe A, Seibert I, Klimkait T, van der Kooy F. Ethnopharmacology in overdrive: The remarkable anti-HIV activity of
Artemisia annua.
J Ethnopharmacol 2012;141:854-9.DOI:
10.1016/j.jep.2012.03.024. PMID:
22465592.
41. Oguariri RM, Adelsberger JW, Baseler MW, Imamichi T. Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication.
Virus Res 2010;153:269-76.DOI:
10.1016/j.virusres.2010.08.018. PMID:
20800626. PMCID:
PMC2956596.
42. Jana S, Iram S, Thomas J, Hayat MQ, Pannecouque C, Dehaen W. Application of the triazolization reaction to afford dihydroartemisinin derivatives with anti-HIV activity.
Molecules 2017;22:303.DOI:
10.3390/molecules22020303. PMID:
28218680. PMCID:
PMC6155659.
43. Efferth T, Marschall M, Wang X, Huong SM, Hauber I, Olbrich A, et al. Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses.
J Mol Med 2002;80:233-42.DOI:
10.1007/s00109-001-0300-8. PMID:
11976732.
44. Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of Hepatitis B virus infection and impact of vaccination on disease.
Clin Liver Dis 2016;20:607-28.DOI:
10.1016/j.cld.2016.06.006. PMCID:
PMC5582972.
45. Orosco F. Recent advances in peptide-based nanovaccines for re-emerging and emerging infectious diseases.
J Adv Biotechnol Exp Ther 2024;7:106-17.DOI:
10.5455/jabet.2024.d10.
46. Tsai E. Review of Current and potential treatments for chronic Hepatitis B virus infection. Gastroenterol Hepatol 2021;17:367-76.
47. Khalil MAM, Khalil MAU, Khan TFT, Tan J. Drug-induced hematological cytopenia in kidney transplantation and the challenges it poses for kidney transplant physicians.
J Transplant 2018;2018:e9429265.DOI:
10.1155/2018/9429265. PMCID:
PMC6093016.
48. Su KH, Su SY, Ko CY, Cheng YC, Huang SS, Chao J. Ethnopharmacological survey of traditional chinese medicine pharmacy prescriptions for dysmenorrhea.
Front Pharmacol 2021;12:746777.DOI:
10.3389/fphar.2021.746777. PMCID:
PMC8724257.
49. Chizzola R, Gansinger D. Chemical composition and antioxidant activity of
Artemisia argyi essential oil and hydrolate.
Compounds 2023;3:521-31.DOI:
10.3390/compounds3030037.
50. Gong PY, Yuan ZX, Gu JJ, Tan R, Li JC, Ren Y, et al. anti-HBV activities of three compounds extracted and purified from
Herpetospermum seeds.
Molecules 2017;22:14.DOI:
10.3390/molecules22010014. PMID:
28035986. PMCID:
PMC6155818.
51. Zhang Z, Fu X, Wang Y, Wang J, Feng S, Zhao Z, et al.
In vivo anti-hepatitis B activity of
Artemisia argyi essential oil-loaded nanostructured lipid carriers. Study of its mechanism of action by network pharmacology and molecular docking.
Phytomedicine 2023;116:154848.DOI:
10.1016/j.phymed.2023.154848.
52. Laine RF, Albecka A, van de Linde S, Rees EJ, Crump CM, Kaminski CF. Structural analysis of herpes simplex virus by optical super-resolution imaging.
Nat Commun 2015;6:5980.DOI:
10.1038/ncomms6980. PMID:
25609143. PMCID:
PMC4338551.
53. Li W, Wang XH, Luo Z, Liu LF, Yan C, Yan CY, et al. Traditional Chinese Medicine as a Potential Source for HSV-1 Therapy by Acting on Virus or the Susceptibility of Host.
Int J Mol Sci 2018;19:3266.DOI:
10.3390/ijms19103266. PMID:
30347851. PMCID:
PMC6213986.
54. Richards CM, Case R, Hirst TR, Hill TJ, Williams NA. protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice.
J Virol 2003;77:6692-9.DOI:
10.1128/JVI.77.12.6692-6699.2003. PMCID:
PMC156198.
55. Kolawole OM, Amuda OO, Nzurumike C, Suleiman MM, Ikhevha Ogah J. Seroprevalence and co-infection of human immunodeficiency virus (HIV) and herpes simplex virus (HSV) among pregnant women in Lokoja, North-Central Nigeria.
Iran Red Crescent Med J 2016;18:e25284.DOI:
10.5812/ircmj.25284. PMID:
28180012. PMCID:
PMC5286443.
56. Silva GS, Richards GA, Baker T, Amin PR. Encephalitis and myelitis in tropical countries: Report from the task force on tropical diseases by the World Federation of Societies of Intensive and Critical Care Medicine.
J Crit Care 2017;42:355-9.DOI:
10.1016/j.jcrc.2017.11.001.
57. James SH, Prichard MN. Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance.
Curr Opin Virol 2014;8:54-61.DOI:
10.1016/j.coviro.2014.06.003. PMID:
25036916.
58. Orosco FL. Breaking the chains: Advancements in antiviral strategies to combat Nipah virus infections.
Int J One Health 2023:122-133.DOI:
10.14202/IJOH.2023.122-133.
59. Xiao J, Liu P, Hu Y, Guo Y, Sun P, Zheng J, et al. Antiviral activities of
Artemisia vulgaris L. extract against herpes simplex virus.
Chin Med 2023;18:21.DOI:
10.1186/s13020-023-00711-1. PMID:
36855145. PMCID:
PMC9972753.
60. Liu P, Zhong L, Xiao J, Hu Y, Liu T, Ren Z, et al. Ethanol extract from
Artemisia argyi leaves inhibits HSV-1 infection by destroying the viral envelope.
Virol J 2023;20:8.DOI:
10.1186/s12985-023-01969-5. PMCID:
PMC9841929.